Home | Technology | Market Opportunity
Market Opportunity
The market need
The KineGraph VMA™ is intended to address the need for an improved functional diagnostic test for the spine. In the currently-used end-range x-ray method, patients bend as far as they can, x-rays are taken of the bent spine, and then the quantity of intervertebral motion is measured manually (protractor and ruler). This method gives inconclusive results in about 85% of cases1,2, cannot discern normal* and abnormal motion, and can only identify the grossest of instabilities.
The KineGraph VMA solution
Pilot studies reveal that the KineGraph VMA™ has the potential to address several challenges with the current standard of care.3 Additionally, the KineGraph VMA™ could prove game-changing for device design. There are currently over 70 motion-preserving spine devices, but it is impossible to distinguish among their kinematics in vivo. The rich set of biomechanical data from the KineGraph VMA™ is intended to give a more complete view of device performance and the effects on adjacent levels, which could lead to more biomechanically appropriate designs.
Broad patient population
The KineGraph VMA addresses a broad patient population. The following table lists some patient populations that are the targets of current and future clinical studies.
| Patient Population |
| Instability and spondylolisthesis |
| Stenosis |
| Degenerative disc disease |
| Discography patients |
Market size
The aim is for the KineGraph to replace the end-range x-ray method of spine functional testing. In the U.S., end-range x-rays are currently ordered 1.6 million times per year for pre-fusion patient work-ups and follow-up testing. Add to this the clinical trials services market, and this opportunity could generate revenues well in excess of $500 million annually in the U.S. market.
*Normal as used here refers to the statistical norm among a population of asymptomatic subjects.
- Murphy D, Hurwitz E. A theoretical model for the development of a diagnosis-based clinical decision rule for the management of patients with spinal pain. Musculoskeletal Disorders 2007; 8:75
- Waddell G. The Back Pain Revolution. Second Edition. New York: Churchill Livingstone, 2004
- Breen AC, Muggleton JM, Mellor FE. An Objective Spinal Motion Image Assessment (OSMIA): reliability, accuracy, and exposure data. BMC Musculoskeletal Disorders 2006;
7:1-10


